Stockreport

Ionis: Good Value With Non-Binary Upside [Seeking Alpha]

AKCEA THERAPEUTICS  (AKCA) 
Last akcea therapeutics earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.akceatx.com/media-investors/press-releases
PDF Ionis: Good Value With Non-Binary UpsideSummaryIonis has a diverse pipeline that targets multiple disease categories.Its $500 mm annual revenue stems from licensing fees [Read more]